Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

The Trump administration‘s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is sowing ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns among medical experts.

The FDA has already delayed the approval of Novavax’s updated Covid vaccine, requiring the company to carry out a new ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...